Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Foreign genes expression in rat vascular smooth muscle]

A Q Yao1, S D Sun, X J Zhu

  • 1Institute of Cardiovascular Research, Beijing Medical University.

Zhonghua Yi Xue Za Zhi
|April 1, 1994
PubMed
Summary

Vascular smooth muscle cells (VSMCs) can be genetically modified to deliver therapeutic genes for cardiovascular diseases. Successful gene transfer and expression were confirmed in VSMCs, supporting their potential in gene therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cautious application of multifocal intraocular lenses in children with congenital cataracts].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2024
Same author

[Bioinformatics-based analysis of the effect of general Transcription Factor IIH on prognosis of Prostate cancer].

Zhonghua yi xue za zhi·2024
Same author

[Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2023
Same author

[PD-1 inhibitor in chronic active Epstein-Barr virus infection: a report of six cases and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2023
Same author

[Establishment and preliminary application of quantitative real-time PCR assay for the detection of SARS-CoV-2 subgenomic nucleocapsid RNA].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2023
Same author

[Comparison of the efficacy and safety of 2 low-dose rituximab regimens in the second-line treatment of primary immune thrombocytopenia in children].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2022

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Cardiovascular diseases remain a leading cause of mortality worldwide.
  • Gene therapy offers a promising avenue for treating complex cardiovascular conditions.
  • Targeting specific cell types like vascular smooth muscle cells (VSMCs) is crucial for effective gene delivery.

Purpose of the Study:

  • To construct retroviral vectors carrying reporter genes (LacZ) or therapeutic genes (human Pro-UK and tPA).
  • To evaluate the feasibility of genetically modifying rat VSMCs using these vectors.
  • To assess the potential of VSMCs as cellular targets for cardiovascular gene therapy.

Main Methods:

  • Construction of three retroviral vectors: pN2-LacZ, pN2-CMV-ProUK, and pN2-CMV-tPA.
  • Transfection of rat VSMCs via calcium phosphate coprecipitation or pseudovirus infection.
  • Selection of transfected cells using G418 and confirmation of gene integration via Southern blot analysis.

Main Results:

  • Successful integration of foreign genes (LacZ, Pro-UK, tPA) into the VSMC genome was confirmed.
  • Expression of the introduced genes was detected within the transfected VSMCs.
  • Demonstrated successful genetic modification of VSMCs with therapeutic genes.

Conclusions:

  • Rat vascular smooth muscle cells (VSMCs) are amenable to genetic modification.
  • VSMCs can serve as effective cellular vehicles for delivering therapeutic genes.
  • VSMCs show promise as a cellular target for gene therapy in cardiovascular diseases.

Related Experiment Videos